Baker Bros. Advisors Lp

Insider Reports History

Entity
Company
Location
860 Washington Street, 3 Rd Floor, New York, NY
Signature
By: Baker Bros. Advisors LP, Name: Scott L. Lessing, Title: President /s/ Scott L. Lessing
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Baker Bros. Advisors Lp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
INCYTE CORP Director, 10%+ Owner Common Stock 28.2M $1.86B $66.10 Sep 30, 2024 Indirect
BeiGene, Ltd. Director American Depositary Shares 8.74M $1.63B $186.50 Dec 9, 2024 Indirect
ACADIA PHARMACEUTICALS INC Director, 10%+ Owner Common Stock 39.3M $667M $16.94 May 29, 2024 Indirect
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock Warrant (right to buy) 2.49M $648M $260.00 Mar 21, 2024 Indirect
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 1.79M $503M $280.00 Jun 25, 2024 Indirect
Kymera Therapeutics, Inc. Director Prefunded Warrants 9.63M $392M $40.75 Aug 21, 2024 Indirect
BICYCLE THERAPEUTICS PLC Director, 10%+ Owner Non-Voting Ordinary Shares 17.8M $382M $21.42 Jun 17, 2024 Indirect
TScan Therapeutics, Inc. Director Warrants to purchase Common Stock 43.2M $308M $7.13 Apr 19, 2024 Indirect
Kymera Therapeutics, Inc. Director Common Stock 5.52M $256M $46.41 Aug 20, 2024 Indirect
BICYCLE THERAPEUTICS PLC Director, 10%+ Owner American Depositary Shares 10M $153M $15.34 Dec 16, 2024 Indirect
Kiniksa Pharmaceuticals International, plc Director Class A Ordinary Shares 2.73M $68.2M $24.99 Oct 4, 2024 Indirect
Prelude Therapeutics Inc Director, 10%+ Owner Warrants to purchase Common Stock 18M $56.6M $3.15 Dec 13, 2023 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Warrants to purchase Common Stock 3.08M $45.8M $14.85 Jun 25, 2024 Indirect
IGM Biosciences, Inc. Director, 10%+ Owner Common Stock 3.76M $43.4M $11.54 Sep 30, 2024 Indirect
DBV Technologies S.A. Director, 10%+ Owner Ordinary Shares 14.6M $25.4M $1.74 Jun 13, 2022 Indirect
BeiGene, Ltd. Director Ordinary Shares 126K $25.2M $200.00 Dec 9, 2024 Indirect
INCYTE CORP Director, 10%+ Owner Common Stock 281K $18.6M $66.10 Sep 30, 2024 Direct
KALA BIO, Inc. 10%+ Owner Common Stock 803K $3.82M $4.75 Jun 28, 2024 Indirect
BeiGene, Ltd. Director American Depositary Shares 10.4K $1.94M $186.50 Dec 9, 2024 Direct
ACADIA PHARMACEUTICALS INC Director, 10%+ Owner Common Stock 103K $1.74M $16.94 May 29, 2024 Direct
Atreca, Inc. Former 10% Owner Class A common stock 2.97M $1.2M $0.40 Oct 19, 2023 Indirect
Kiniksa Pharmaceuticals International, plc Director Class A Ordinary Shares 14.8K $371K $24.99 Oct 4, 2024 Direct
Neurogene Inc. Director, Former 10% Owner Common Stock 415K $287K $0.69 Dec 18, 2023 Indirect
vTv Therapeutics Inc. Director Non- Qualified Stock Option (right to buy) 983 $11.6K $11.81 Jun 25, 2024 Indirect
BeiGene, Ltd. Director Ordinary Shares 1 $200 $200.00 Dec 9, 2024 Direct
Neurogene Inc. Director, Former 10% Owner Common Stock 113 $78.30 $0.69 Dec 18, 2023 Direct
BELLICUM PHARMACEUTICALS, INC 10%+ Owner Warrants (right to buy) 14.2M Nov 22, 2023 Indirect
DBV Technologies S.A. Director, 10%+ Owner American Depositary Shares 13.4M Jun 13, 2022 Indirect
DBV Technologies S.A. Director, 10%+ Owner Pre-Funded Warrants 11.7M Jun 13, 2022 Indirect
vTv Therapeutics Inc. Director Prefunded Warrants 2.82M Mar 5, 2024 Indirect
Kiniksa Pharmaceuticals, Ltd. Director Class A Common Shares 2.73M Jun 5, 2024 Indirect
Neurogene Inc. Director, Former 10% Owner Prefunded Warrants 2.66M Dec 18, 2023 Indirect
BELLICUM PHARMACEUTICALS, INC 10%+ Owner Common Stock 2.17M Nov 22, 2023 Indirect
Neoleukin Therapeutics, Inc. Director, Former 10% Owner Pre-funded Warrants 1.52M Oct 5, 2023 Indirect
Immunocore Holdings plc Director American Depositary Shares 1.41M May 28, 2024 Indirect
vTv Therapeutics Inc. Director Common Stock 89.3K Mar 5, 2024 Indirect
BeiGene, Ltd. Director Share Option (Right to Buy) 68.3K Jun 5, 2024 Indirect
TScan Therapeutics, Inc. Director Non- Qualified Stock Option (right to buy) 47.5K Jun 12, 2024 Indirect
Aeglea BioTherapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 40K Jun 8, 2021 Indirect
Kodiak Sciences Inc. Director, 10%+ Owner Non- Qualified Stock Options (right to buy) 40K Jun 28, 2024 Indirect
Kymera Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 32K Mar 28, 2024 Indirect
ACADIA PHARMACEUTICALS INC Director, 10%+ Owner Non- Qualified Stock Option (right to buy) 31.9K May 29, 2024 Indirect
IGM Biosciences, Inc. Director, 10%+ Owner Non- Qualified Stock Option (right to buy)uy) 29.4K Mar 12, 2024 Indirect
Kiniksa Pharmaceuticals International, plc Director Non- Qualified Share Option (right to buy) 28.4K Oct 4, 2024 Indirect
BICYCLE THERAPEUTICS plc Director, 10%+ Owner Share Option (Right to Buy) 24K Apr 18, 2024 Indirect
Talis Biomedical Corp Director, 10%+ Owner Non- Qualified Stock Option (right to buy) 23.7K Jun 9, 2023 Indirect
Prelude Therapeutics Inc Director, 10%+ Owner Non- Qualified Stock Option (right to buy) 23.5K Jun 14, 2024 Indirect
ACADIA PHARMACEUTICALS INC Director, 10%+ Owner Non-Qualified Stock Options (right to buy) 22.1K Jun 1, 2023 Indirect
Kiniksa Pharmaceuticals, Ltd. Director Class A Common Shares 14.8K Jun 5, 2024 Direct
Immunocore Holdings plc Director Non-Qualified Share Option (right to buy) 12.9K May 28, 2024 Indirect
INCYTE CORP Director, 10%+ Owner Non- Qualified Stock Options (right to buy) 12.5K Jun 12, 2024 Indirect
MADRIGAL PHARMACEUTICALS, INC. Director Non- Qualified Stock Options (right to buy) 2.21K Jun 25, 2024 Indirect
Seagen Inc. Director, Former 10% Owner Common Stock 0 $229.00 Dec 14, 2023 Direct
Seagen Inc. Director, Former 10% Owner Common Stock 0 $229.00 Dec 14, 2023 Indirect
Seagen Inc. Director, Former 10% Owner Stock Options (right to buy) 0 Dec 14, 2023 Indirect

Insider Reports Filed by Baker Bros. Advisors Lp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCYC BICYCLE THERAPEUTICS PLC Dec 13, 2024 10 $21.2M 4 Dec 17, 2024 Director, 10%+ Owner
BGNE BeiGene, Ltd. Dec 9, 2024 4 -$194M 4 Dec 10, 2024 Director
KNSA Kiniksa Pharmaceuticals International, plc Oct 4, 2024 4 $0 4 Oct 8, 2024 Director
IGMS IGM Biosciences, Inc. Sep 30, 2024 2 $0 4 Oct 2, 2024 Director, 10%+ Owner
INCY INCYTE CORP Sep 30, 2024 2 $0 4 Oct 2, 2024 Director, 10%+ Owner
KYMR Kymera Therapeutics, Inc. Aug 20, 2024 3 $106M 4 Aug 22, 2024 Director
IGMS IGM Biosciences, Inc. Jun 28, 2024 2 $0 4 Jul 2, 2024 Director, 10%+ Owner
INCY INCYTE CORP Jun 28, 2024 2 $0 4 Jul 2, 2024 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Jun 28, 2024 2 $0 4 Jul 2, 2024 Director, 10%+ Owner
KALA KALA BIO, Inc. Jun 28, 2024 0 $0 3 Jun 28, 2024 10%+ Owner
VTVT vTv Therapeutics Inc. Jun 25, 2024 4 $0 4 Jun 27, 2024 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 25, 2024 4 $0 4 Jun 27, 2024 Director
TRDA Entrada Therapeutics, Inc. Jun 25, 2024 2 $50M 4 Jun 26, 2024 10%+ Owner
BCYC BICYCLE THERAPEUTICS PLC Jun 17, 2024 4 $0 4 Jun 20, 2024 Director, 10%+ Owner
PRLD Prelude Therapeutics Inc Jun 14, 2024 2 $0 4 Jun 18, 2024 Director, 10%+ Owner
INCY INCYTE CORP Jun 12, 2024 6 -$328M 4 Jun 14, 2024 Director, 10%+ Owner
TCRX TScan Therapeutics, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 5, 2024 4 $0 4 Jun 7, 2024 Director
BGNE BeiGene, Ltd. Jun 5, 2024 4 $0 4 Jun 7, 2024 Director, 10%+ Owner
ACAD ACADIA PHARMACEUTICALS INC May 29, 2024 4 $0 4 May 31, 2024 Director, 10%+ Owner
BCYC BICYCLE THERAPEUTICS plc May 29, 2024 2 $367M 4 May 29, 2024 Director, 10%+ Owner
IMCR Immunocore Holdings plc May 28, 2024 2 $0 4 May 29, 2024 Director
IMCR Immunocore Holdings plc May 28, 2024 0 $0 3 May 29, 2024 Director
INCY INCYTE CORP May 7, 2024 4 $1.47M 4 May 9, 2024 Director, 10%+ Owner
TCRX TScan Therapeutics, Inc. Apr 19, 2024 2 $69M 4 Apr 23, 2024 Director
BCYC BICYCLE THERAPEUTICS plc Apr 18, 2024 4 $0 4 Apr 22, 2024 Director, 10%+ Owner
BCYC BICYCLE THERAPEUTICS plc Apr 18, 2024 0 $0 3 Apr 18, 2024 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 29, 2024 2 $0 4 Apr 1, 2024 Director, 10%+ Owner
INCY INCYTE CORP Mar 28, 2024 2 $0 4 Apr 1, 2024 Director, 10%+ Owner
KYMR Kymera Therapeutics, Inc. Mar 28, 2024 2 $0 4 Apr 1, 2024 Director
KYMR Kymera Therapeutics, Inc. Mar 28, 2024 0 $0 3 Apr 1, 2024 Director
IGMS IGM Biosciences, Inc. Mar 26, 2024 8 $3.43M 4 Mar 28, 2024 Director, 10%+ Owner
MDGL MADRIGAL PHARMACEUTICALS, INC. Mar 21, 2024 2 $275M 4 Mar 25, 2024 Director
IGMS IGM Biosciences, Inc. Mar 12, 2024 2 $0 4 Mar 14, 2024 Director, 10%+ Owner
VTVT vTv Therapeutics Inc. Mar 5, 2024 4 $0 4 Mar 7, 2024 Director
VTVT vTv Therapeutics Inc. Feb 27, 2024 0 $0 3 Mar 7, 2024 Director
IGMS IGM Biosciences, Inc. Dec 29, 2023 2 $0 4 Jan 3, 2024 Director, 10%+ Owner
INCY INCYTE CORP Dec 29, 2023 2 $0 4 Jan 3, 2024 Director, 10%+ Owner
NGNE Neurogene Inc. Dec 18, 2023 8 $0 4 Dec 20, 2023 Director, Former 10% Owner
SGEN Seagen Inc. Dec 14, 2023 13 -$10.2B 4 Dec 18, 2023 Director, Former 10% Owner
IGMS IGM Biosciences, Inc. Dec 13, 2023 12 $3.43M 4 Dec 15, 2023 Director, 10%+ Owner
MDGL MADRIGAL PHARMACEUTICALS, INC. Dec 13, 2023 24 $22.5M 4 Dec 14, 2023 Director
PRLD Prelude Therapeutics Inc Dec 13, 2023 2 $25M 4 Dec 13, 2023 Director, 10%+ Owner
MDGL MADRIGAL PHARMACEUTICALS, INC. Dec 12, 2023 30 $7.55M 4 Dec 14, 2023 Director
BLCM BELLICUM PHARMACEUTICALS, INC Nov 22, 2023 4 $212 4 Nov 24, 2023 10%+ Owner
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 21, 2023 20 $12.1M 4 Nov 21, 2023 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 17, 2023 30 $11.9M 4 Nov 21, 2023 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 14, 2023 4 $7.81M 4 Nov 15, 2023 Director
BGNE BeiGene, Ltd. Nov 14, 2023 2 -$199M 4 Nov 14, 2023 Director, 10%+ Owner
MDGL MADRIGAL PHARMACEUTICALS, INC. Nov 13, 2023 30 $15.8M 4 Nov 15, 2023 Director
BCEL Atreca, Inc. Oct 19, 2023 2 -$111K 4 Oct 23, 2023 Former 10% Owner
NLTX Neoleukin Therapeutics, Inc. Oct 5, 2023 4 $0 4 Oct 10, 2023 Director, 10%+ Owner
MDGL MADRIGAL PHARMACEUTICALS, INC. Oct 3, 2023 2 $250M 4 Oct 5, 2023 Director
IGMS IGM Biosciences, Inc. Sep 29, 2023 2 $0 4 Oct 3, 2023 Director
INCY INCYTE CORP Sep 29, 2023 2 $0 4 Oct 3, 2023 Director, 10%+ Owner
NLTX Neoleukin Therapeutics, Inc. Aug 15, 2023 12 $1.46M 4 Aug 17, 2023 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Jun 30, 2023 2 $0 4 Jul 5, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Jun 30, 2023 2 $0 4 Jul 5, 2023 Director
INCY INCYTE CORP Jun 30, 2023 2 $0 4 Jul 5, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Jun 26, 2023 2 $45M 4 Jun 28, 2023 Director
PRLD Prelude Therapeutics Inc Jun 16, 2023 2 $0 4 Jun 21, 2023 Director, 10%+ Owner
BGNE BeiGene, Ltd. Jun 15, 2023 4 $0 4 Jun 20, 2023 Director, 10%+ Owner
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 15, 2023 2 $0 4 Jun 20, 2023 Director
MDGL MADRIGAL PHARMACEUTICALS, INC. Jun 15, 2023 0 $0 3 Jun 20, 2023 Director
INCY INCYTE CORP Jun 14, 2023 4 $0 4 Jun 16, 2023 Director, 10%+ Owner
TCRX TScan Therapeutics, Inc. Jun 13, 2023 2 $0 4 Jun 15, 2023 Director
TLIS Talis Biomedical Corp Jun 9, 2023 2 $0 4 Jun 13, 2023 Director, 10%+ Owner
NLTX Neoleukin Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 12, 2023 Director
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 6, 2023 4 $0 4 Jun 8, 2023 Director
ACAD ACADIA PHARMACEUTICALS INC Jun 1, 2023 3 $0 4 Jun 5, 2023 Director, 10%+ Owner
TCRX TScan Therapeutics, Inc. Jun 1, 2023 2 $75M 4 Jun 2, 2023 Director
SGEN Seagen Inc. May 31, 2023 2 $0 4 Jun 2, 2023 Director, 10%+ Owner
ACAD ACADIA PHARMACEUTICALS INC May 22, 2023 18 $23.1M 4 May 24, 2023 Director, 10%+ Owner
PRLD Prelude Therapeutics Inc May 22, 2023 4 $75M 4 May 24, 2023 Director, 10%+ Owner
BLCM BELLICUM PHARMACEUTICALS, INC May 5, 2023 0 $0 3 May 5, 2023 10%+ Owner
SGEN Seagen Inc. May 1, 2023 9 $642K 4 May 3, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Apr 4, 2023 1 $0 4 Apr 6, 2023 Director, 10%+ Owner
INCY INCYTE CORP Mar 31, 2023 2 $0 4 Apr 4, 2023 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 31, 2023 2 $0 4 Apr 4, 2023 Director, 10%+ Owner
INCY INCYTE CORP Mar 13, 2023 4 $910K 4 Mar 15, 2023 Director, 10%+ Owner
ACAD ACADIA PHARMACEUTICALS INC Jan 12, 2023 4 $157K 4 Jan 17, 2023 Director, 10%+ Owner
INCY INCYTE CORP Dec 30, 2022 2 $0 4 Jan 4, 2023 Director, 10%+ Owner
INCY INCYTE CORP Sep 30, 2022 2 $0 4 Oct 4, 2022 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Director, 10%+ Owner
INCY INCYTE CORP Jun 30, 2022 2 $0 4 Jul 1, 2022 Director, 10%+ Owner
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2022 3 $0 4 Jun 30, 2022 Director
BGNE BeiGene, Ltd. Jun 22, 2022 3 $0 4 Jun 24, 2022 Director, 10%+ Owner
PRLD Prelude Therapeutics Inc Jun 17, 2022 1 $0 4 Jun 22, 2022 Director, 10%+ Owner
INCY INCYTE CORP Jun 15, 2022 3 $0 4 Jun 17, 2022 Director, 10%+ Owner
DBVT DBV Technologies S.A. Jun 13, 2022 4 $0 4 Jun 13, 2022 Director, 10%+ Owner
TLIS Talis Biomedical Corp Jun 10, 2022 1 $0 4 Jun 13, 2022 Director, 10%+ Owner
ACAD ACADIA PHARMACEUTICALS INC Jun 7, 2022 3 $0 4 Jun 9, 2022 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Jun 2, 2022 12 $4.45M 4 Jun 6, 2022 Director, 10%+ Owner
TRDA Entrada Therapeutics, Inc. Jun 2, 2022 6 $261K 4 Jun 6, 2022 10%+ Owner
TCRX TScan Therapeutics, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director, 10%+ Owner
KOD Kodiak Sciences Inc. May 25, 2022 16 $2.36M 4 May 27, 2022 Director, 10%+ Owner
TRDA Entrada Therapeutics, Inc. May 20, 2022 10 $282K 4 May 24, 2022 10%+ Owner
TRDA Entrada Therapeutics, Inc. May 16, 2022 8 $431K 4 May 18, 2022 10%+ Owner
KOD Kodiak Sciences Inc. May 16, 2022 14 $2.7M 4 May 18, 2022 Director, 10%+ Owner
SGEN Seagen Inc. May 13, 2022 3 $0 4 May 17, 2022 Director, 10%+ Owner
NLTX Neoleukin Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
TCRX TScan Therapeutics, Inc. May 10, 2022 8 $2.56M 4 May 12, 2022 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Apr 1, 2022 2 $65M 4 Apr 5, 2022 Director, 10%+ Owner
INCY INCYTE CORP Mar 31, 2022 2 $0 4 Apr 4, 2022 Director, 10%+ Owner
IGMS IGM Biosciences, Inc. Mar 12, 2022 1 $0 4 Mar 15, 2022 Director, 10%+ Owner
INCY INCYTE CORP Mar 8, 2022 14 $29M 4 Mar 10, 2022 Director, 10%+ Owner
SGEN Seagen Inc. Mar 8, 2022 4 $702K 4 Mar 10, 2022 Director, 10%+ Owner
INCY INCYTE CORP Feb 17, 2022 8 $35.7M 4 Feb 22, 2022 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Feb 15, 2022 10 $21.8M 4 Feb 17, 2022 Director, 10%+ Owner
INCY INCYTE CORP Feb 10, 2022 7 $107M 4 Feb 14, 2022 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Jan 27, 2022 12 $18.1M 4 Jan 31, 2022 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Jan 21, 2022 10 $28.8M 4 Jan 25, 2022 Director, 10%+ Owner
INCY INCYTE CORP Dec 31, 2021 2 $0 4 Jan 4, 2022 Director, 10%+ Owner
INCY INCYTE CORP Dec 15, 2021 10 $116M 4 Dec 17, 2021 Director, 10%+ Owner
TRDA Entrada Therapeutics, Inc. Dec 14, 2021 0 $0 3 Dec 16, 2021 10%+ Owner
SGEN Seagen Inc. Nov 30, 2021 20 -$63.4M 4 Dec 2, 2021 Director, 10%+ Owner
TLIS Talis Biomedical Corp Nov 18, 2021 1 $218K 4 Nov 19, 2021 Director, 10%+ Owner
INCY INCYTE CORP Sep 30, 2021 2 $0 4 Oct 4, 2021 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Sep 29, 2021 7 $8.33M 4 Oct 1, 2021 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Sep 15, 2021 3 $3.01M 4 Sep 17, 2021 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Sep 7, 2021 2 $5.37M 4 Sep 9, 2021 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Aug 17, 2021 10 $10M 4 Aug 19, 2021 Director, 10%+ Owner
KOD Kodiak Sciences Inc. Aug 11, 2021 10 $8.96M 4 Aug 13, 2021 Director, 10%+ Owner
TCRX TScan Therapeutics, Inc. Jul 20, 2021 6 $21.4M 4 Jul 22, 2021 Director
TCRX TScan Therapeutics, Inc. Jul 15, 2021 0 $0 3 Jul 15, 2021 Director, 10%+ Owner
INCY INCYTE CORP Jun 30, 2021 2 $0 4 Jul 2, 2021 Director, 10%+ Owner
KNSA Kiniksa Pharmaceuticals, Ltd. Jun 29, 2021 1 $0 4 Jul 1, 2021 Director
KOD Kodiak Sciences Inc. Jun 28, 2021 14 $23.7M 4 Jun 30, 2021 Director, 10%+ Owner
ACAD ACADIA PHARMACEUTICALS INC Jun 22, 2021 3 $0 4 Jun 24, 2021 Director, 10%+ Owner
PRLD Prelude Therapeutics Inc Jun 18, 2021 1 $0 4 Jun 22, 2021 Director, 10%+ Owner
BGNE BeiGene, Ltd. Jun 16, 2021 3 $0 4 Jun 21, 2021 Director, 10%+ Owner
AGLE Aeglea BioTherapeutics, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
INCY INCYTE CORP May 26, 2021 3 $0 4 May 28, 2021 Director, 10%+ Owner
INCY INCYTE CORP May 14, 2021 4 $759K 4 May 18, 2021 Director, 10%+ Owner
SGEN Seagen Inc. May 14, 2021 7 $666K 4 May 18, 2021 Director, 10%+ Owner
NLTX Neoleukin Therapeutics, Inc. May 11, 2021 1 $0 4 May 13, 2021 Director